Kymera Therapeutics, Inc. (KYMR)

85.63 -4.05 (-4.52%) USD  |  NASDAQ  |  Dec 15, 16:00
85.55 -0.08 (-0.09%) After-Hours: 19:58
More

Kymera Therapeutics EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sanofi --
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade